Advances in Heart Health: Semaglutide, Plant-Based Diet, and New Drugs

In this episode of Heart Doc VIP with Dr. Joel Kahn, we dive deep into the ever-evolving research on aspirin, a staple in cardiology. Dr. Kahn revisits three pivotal studies from 2018 that cast doubt on the universal need for daily aspirin. Fast forward to 2020, we delve into two papers highlighting the benefits of aspirin for those with high calcium CT scores. By 2023, new insights reveal the risks of discontinuing aspirin post-heart attack, even if it's years later. Alongside these insights, Dr. Kahn touches on a range of topics, including the intriguing banana-blueberry smoothie study. Join us for a week full of enlightening discoveries from the Kahn Center for Cardiac Longevity.